Reddit Posts
GNTA (soon SAEN) trading below net cash, anyone else watching this Italian defense/aerospace consolidator?
Genenta, evolving into Saentra Forge, has signed a Binding Offer with SΓ²phia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs
News! Genenta, evolving into Saentra Forge, has signed a Binding Offer with SΓ²phia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs
GNTA: Why March 26 could be a major catalyst (and why the market might be underpricing it)
Genenta (GNTA): This is no longer a biotech story β itβs a capital allocation story.
My portfolio: $YYAI $PSTV $GNTA
$GNTA new US-Italian NATO constellation since yesterdayβs news.
$GNTA - NATO partnering in new transformation.
$GNTA - NATO partnering in new transformation.
Genenta (GNTA) going crazy pre-market (+300%)
Letting ChatGPT Agent Mode Run My $100 Robinhood Micro-Cap Portfolio for 6 Months - Day 1
Mentions
My AI Slop Analysis: (1/2) GNTA β Genenta Science, aka soon-to-be Saentra Forge β HARD AVOID Look at this piece of shit sideways for two seconds and you already smell it: an Italian gene-therapy micro-cap that gave up on curing brain cancer and decided to become a defense contractor instead. The stock is 1.61 bucks, which is 84 percent below where it was a year ago. The old cancer drug Temferon is dead β the board terminated the underlying San Raffaele hospital license in May and there are literally two patients left in the trial. That whole story is a corpse. Now they wanna sell you a rebrand. The pitch on Reddit and the little pennystock corners is ooohhh trading below net cash. That is the entire bull thesis and it is horseshit. Yes, if you use the 23.6 million ADS number that Yahoo shows and multiply by 1.61, you get a 38 million dollar market cap and there is 30 million bucks of cash and Italian government bonds sitting on the balance sheet. Sounds sexy. It is not. Five weeks ago, on May 29, this company printed 24.6 million brand-new ordinary shares at 39 euro cents apiece and handed them to three Italian dudes to buy 100 percent of a company called A.T.C. that makes tactical rifles. That is not a hypothetical. That happened. It closed in front of an Italian notary. The real share count is roughly 48 million, not 23.6 million. The real market cap is 77 million bucks, not 38. You are not buying below net cash. You are buying at three-plus times net cash and the retail pitch is a static snapshot that is already dead on arrival. While that is going on, there is a mandatory convertible bond hanging in the closet β up to 20 million euros, 7.5 million already drawn from an Italian public-law foundation called Enea, that pays out in a variable number of shares depending on the price. That is the exact toxic-convertible shape that eats floats for breakfast, and get this: the company is currently suing the counterparty in the Milan courts trying to declare the whole thing null and void. So there is either 12.5 million more euros of dilution ammo pointed at your face, or an ugly settlement, or a judge tells them to go pound sand. Any of those outcomes is somewhere between meh and terrible. The kicker is the governance. The founder-CEO Pierluigi Paracchi cut a shareholders' agreement in January with a foundation called Praexidia β a private Italian club of defense-industry heavies and retired military brass that he himself is the chairman of. Read that again. He wrote a control-lock deal with a foundation he runs. And the primary filing openly says he retains majority voting power at shareholder meetings. So even in the fantasy where the balance sheet is a treasure chest, the treasure chest belongs to him and you get to watch through the window. Insider check on the tape, twelve months back: zero personal cash into the stock. Zero. Not one euro of skin. The only insider Form 4 activity is three grant filings on March 30 β free shares to the CEO, one director, and the CFO, at a subscription price of literally zero dollars. Meanwhile the ADS traded from ten bucks down to 55 cents and back to 1.61 and nobody with a nameplate on the door bought a single share of it with their own money. That is the inverse of a bullish tell. The people closest to the actual books happily accepted more paper for free and put in nothing. (2/2) The pivot narrative β become an industrial consolidator under Italy's Golden Power national-security law, roll up defense and aerospace and cybersecurity β is not fake. They actually closed two deals. But the numbers are tinier than the story. A.T.C. is a rifle shop with maybe 4 million euros of projected revenue this year. Sophia High Tech is a 44-person Naples aerospace machine shop with 8 million euros of projected 2025 sales and 51 percent of it belongs to Genenta. Add it up: combined attributable revenue around 8 million euros, combined attributable EBITDA around 2 to 3 million euros. At a real 55 million dollar enterprise value on the diluted math, you are paying north of twenty times forward EBITDA for a sub-scale European defense micro-cap. Real defense consolidators trade 10 to 14. This one is priced for a story, not a company. Then there is the plumbing bullshit. They already got a Nasdaq minimum-bid-price warning in April when the stock puked to 55 cents. They just cured it in June. The extraordinary shareholder meeting to formally rename the company Saentra Forge got called, then revoked, then called again, and just got adjourned to July 29-30 β the same meeting where they want to vote in a reverse stock split and hand the board authority to increase share capital. So the near-term catalyst calendar looks like: rebrand, reverse split, and pre-authorized dilution machine. Pick your poison. Extra sprinkles on the dumpster: the CFO got demoted from employee to twelve-month consultant on June 1, the whole US subsidiary is being shuttered by end of July, and Paracchi just signed himself a brand-new severance package with twelve months of salary plus a bonus kicker on June 19. When management is bolting a golden parachute onto the founder-chairman right before a highly contested EGM, that is a man who reads the room. Baby lens: this is 0 out of 8 on the scorecard. No revenue, no personal-cash founder skin, active toxic-convert overhang in litigation, control-lock governance, regressed adult six times off the highs, doubling share count on a shell pivot, foreign-private-issuer disclosure gap. Do not throw 500 bucks at it and let it grow. It will not grow. It will pivot again. Only speculative angle: the July 29-30 name-change meeting could produce a rebrand pump and a symbol change to SAEN, which drags in the tourist crowd for a session or two. If you are gonna touch that, wait for a volume-confirmed break above two bucks in the last week of July, hard stop at 1.55, target 2.50 to 3.00 into the print, and sell into it β do not hold through the reverse split. That is a rented seat, not a home. And that is not our style anyway. Bottom line: the retail below net cash narrative is a mirage built on stale share counts. The real cap is double what they think, the cash pile has the founder's fingerprints all over it, and the convertible in the closet is either a dilution grenade or a lawsuit that goes nowhere quick. Zero personal cash from anybody in the corner office in a full year of stock destruction is the trap tell. Skip it, don't chase the July meeting, and if you already own it, use the pop into the EGM to leave.
Happy Friday $VSA $ONCO $OSRH $GNTA
GNTA news [https://www.benzinga.com/pressreleases/26/03/g51501772/genenta-evolving-into-saentra-forge-has-signed-a-binding-offer-with-s-phia-high-tech-an-italian-co](https://www.benzinga.com/pressreleases/26/03/g51501772/genenta-evolving-into-saentra-forge-has-signed-a-binding-offer-with-s-phia-high-tech-an-italian-co)
Also keeping your eyes on RCKT and GNTA
A partnership with NATO sounds promising, but let's not get carried away before we see some concrete results. GNTA's recent price action suggests potential resistance around $5, so that's a level to watch. For a more detailed analysis, this might help: https://aimytrade.io/ticker/GNTA?utm_source=reddit&utm_medium=comment&utm_campaign=RobinHoodPennyStocks
I think GNTA could be today's big runner due to the news and low float. I'm getting some now to see what happens
GNTA seems to have good news not sure how its going to hold in open market
GNTA has no short shares available. Just need volume to create a scare
GNTA [GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains | Nasdaq](https://www.nasdaq.com/articles/gnta-bbio-amrn-jump-after-hours-key-biotech-catalysts-driving-stock-gains)
Last week GNTA surged 1000% in the premarket. I saw it mentioned in another sub. It happens, but not typically in the regular session. BYND wasn't in a single day, but it does happen. I have not been fortunate enough to catch such an upswing, and would definitely miss the top if I did.
In at $GNTA lets see how that goes
Nobody watching GNTA for a nice entry now??
GNTA pulling back is it a good buy now??
idk what GNTA is, but that sucker went 15x after the bell last night
Where do you find infos about GNTA and WGRX?
sheesh still waiting for GNTA6 to drop
Could GNTA fly back to $20??
Bro what the fuck is GNTA where do these plays spawn